Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of access to HIV prevention drug, PrEP, by population group.

Routine pre-exposure prophylaxis (PrEP) for the prevention of HIV began in England in autumn 2020. The UK Health Security Agency’s Sexually Transmitted Infections Surveillance System collects data from sexual health services on PrEP eligibility, offer and use and the number of tablets prescribed. This data is due to be published later in 2022, after a full year of data for 2021 has been reported. Where possible, this will be presented by key population group and geographical region.